In less than 36 hours between the evening of Jan. 12 and the morning of Jan. 14, three local life science companies raised a ...

So far this month, Tune Therapeutics, which has dual headquarters in Seattle and Durham, North Carolina, and Bellevue-based health care tech company Truveta have raised rounds of $175 million and ...

After hours: January 24 at 4:00:09 PM EST Loading Chart for ABEO ...

After hours: January 24 at 7:49:55 PM EST Loading Chart for ITRM ...

Vast Therapeutics is celebrating the new year with Series A funding in excess of $15 million from Shionogi & Co., Ltd. (TYO: 4507) of Japan and a $300,000 award from the Cystic Fibrosis Foundation.

Sanofi S.A. Part Cert 0.06% €8.19M ...

You’ve certainly heard about antibodies, peptides, and even DNA as therapeutics, but what about RNA? In this review, we take a look at what’s happening in a field that some believe may be as big a ...

North Carolina-based biotech Tune Therapeutics has raised $175 million in a Series B that will help it to take its lead epigenetic silencing drug, Tune-401, into clinical testing as a potential ...

There's great news for fans of The Traitors as, with the outcome of this series looking set o go right down to the wire after a huge twist, the final has been extended, meaning the show will begin ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Durham’s Tavros Therapeutics sold to subsidiary of German giant Bayer AG Durham-based Tavros Therapeutics, a precision oncology company spun out of Duke University, has been acquired by a subsidiary ...